NEWS
Filter
January 8, 2026
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
This news release constitutes a “designated news release” for the purposes of Canopy Growth’s prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 Refinances Term Loan due 2027 and Exchanges Convertible Debentures due 2029, Extending Maturities of All Outstanding Indebtedness to Earliest January 2031 While Enhancing Liquidity Profile SMITHS FALLS, ON. January 8, 2026 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has entered into a series of transactions…
December 18, 2025
US President’s order to reschedule cannabis welcomed by Canadian industry
As part of an announcement on Thursday from the Oval Office, President Trump also called on the US Congress to update the definition of hemp-derived cannabinoid products to allow access to “full-spectrum CBD products....
December 15, 2025
Canopy Growth to Acquire MTL Cannabis in $125 Million Deal, Expanding Medical Marijuana Footprint in Canada
Canopy Growth announced Monday that it has agreed to acquire Québec-based MTL Cannabis in a transaction valued at approximately $125 million on a fully diluted equity basis, a deal the company says will significantly strengthen its position in Canada’s medical marijuana market while expanding high-quality flower supply for both domestic and international markets....
December 15, 2025
Canopy Growth signs deal to buy MTL Cannabis in agreement valued at $125M
SMITHS FALLS — Canopy Growth Corp. has signed a deal to buy Quebec-based MTL Cannabis Corp. in a transaction valued at about $125 million. The deal is expected to help boost Canopy Growth’s position in Canada’s medical cannabis market....
December 15, 2025
Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand
This news release constitutes a “designated news release” for the purposes of Canopy Growth’s prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Highly accretive business combination expected to generate significant run-rate synergies of approximately $10 million within 18 months Strengthens Canopy Growth’s presence in Québec with an opportunity to expand national distribution of MTL’s high-quality, budtender-recommended product portfolio2 MTL’s core management team is expected to join Canopy Growth to drive cultivation excellence and enhance the Company’s product quality…
December 4, 2025
Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment
New high-performance AIO vapes and infused pre-roll variety packs further Claybourne’s continued growth as one of the fastest-rising brands[1] in Canada’s adult-use market SMITHS FALLS, ON, December 4, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the national launch of Claybourne Gassers, a new lineup of All-in-One (AIO) vapes featuring liquid diamonds. The launch marks Claybourne’s entry into Canada’s vape categorybuilding on its leadership in high potency infused products. The Claybourne Gassers collection includes three 0.95g liquid diamond…
November 18, 2025
Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels
Expanded formats strengthen Canopy Growth’s medical offering as patient demand rises SMITHS FALLS, ON, November 18, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company’s medical cannabis offerings in the region. The formats include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis Oil Softgels (THC 10mg), and Spectrum Blue Cannabis Oil Softgels (Balanced THC 2.5mg : CBD 3.75mg). These softgels…
November 7, 2025
Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet
Canada adult-use revenue up 30% in Q2 FY2026 and 37% year-to-date, reflecting the benefits of our focused commercial strategy and more disciplined execution Canada medical revenue up 17% in Q2 FY2026 and 15% year-to-date, marking another standout quarter for growth $298MM cash and cash equivalents, which exceeds debt balances by $70MM at September 30, 2025; as a result, conditions that previously raised substantial doubt concerning the Company’s ability to continue as a going concern have been resolved SMITHS FALLS, ON, November 7, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (Nasdaq: CGC) today announced its financial results…
October 24, 2025
Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025
Smiths Falls, ON, October 24, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on November 7, 2025. Following the release of its second quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Tom Stewart, CFO on November 7, 2025 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=EEDC9A65-53FA-40BD-9644-D3ABDCF91E72 Replay Information A replay will be accessible by webcast until 11:59…
October 14, 2025
Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders
SMITHS FALLS, ON, SEPTEMBER 26, 2023 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the voting results from its annual general and special meeting of shareholders held on September 25, 2023 (the “Meeting”). A total of 350,593,653 common shares of the Company (the “Shares”), representing 48.88% of the issued and outstanding Shares, were voted in connection with the Meeting by the Company’s shareholders and proxy holders. All of the matters put forward before the Company’s shareholders for consideration and approval, as set out in the Company’s definitive proxy…